下载文档原格式
植入型心律转复除颤器植入技术(I C D)-标准化文件发布号：（9456-EUATWK-MWUB-WUNN-INNUL-DDQTY-KII植入型心律转复除颤器植入技术概述:（implantable cardiovertor-defibrillator，ICD）是近20多年来经大量的临床实践和循证医学证实的治疗恶性室性心律失常及预防心脏猝死的有效手段。
ICD在人体内能在数秒钟内检测到危及生命的室速和（或）室颤，并进行相应的治疗。
ICD的植入技术主要根据导线的植入方式分为开胸植入和经静脉植入。
目前临床上已普遍采用经静脉植入技术适应症:1．I类适应证（1）因室速、室颤引起的心脏骤停，除外暂时性、可逆性原因（A）。
（2）自发性持续性室速，合并器质性心脏病（B）。
（3）不明原因的晕厥，合并电生理诱发出持续性室速，血流动力学不稳定，药物治疗无效、不能耐受药物治疗（B）。
（4）非持续性室速，有冠状动脉疾病、心肌梗死病史，合并左心室功能低下，电生理检查诱发出持续性室速或室颤，I类抗心律失常药不抑制其发作（BA）。
2．Ⅱ类适应证（1）Ⅱa类适应证：左心室功能低下，LVEF＜30％，心肌梗死后1个月，冠状动脉旁路移植术后3个月（B）。
（2）Ⅱb类适应证①临床推测心脏骤停是由于室颤引起，而由于其他原因不能行电生理检查（C）。
②等待心脏移植，因室速产生严重症状（晕厥）（C）。
③家族性或遗传性的高危状况导致致命性室性心动过速如长QT综合征、肥厚性心肌病（B）。
④非持续性室速，合并冠状动脉疾病，心肌梗死病史、左心室功能低下者，电生理检查诱发出持续性VT/VF（B）。
⑤不明原因晕厥，Jb功能低下，电生理检查诱发出室性心律失常（C）。
⑥不明原因晕厥，家族中有猝死史，合并RBBB+ST抬高（Brugada综合征）（C）。
⑦晕厥合并进展型器质性心脏病，病因难以确定（C）。
3．Ⅲ类适应证（1）原因不明的晕厥，没有可诱发的室性快速心律失常，也无器质性心脏病。
万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据万方数据植入型心律转复除颤器治疗的中国专家共识作者：中华医学会心电生理和起搏分会， 中华医学会心血管病学分会， 中国医师协会心律学专业委员会植入型心律转复除颤器治作者单位：刊名：中华心律失常学杂志英文刊名：Chinese Journal of Cardiac Arrhythmias年，卷(期)：2014,18(4)1.de Vreede-Swaemakwes JJ;Gorgels AP;Dubois-Arbouw WI Out-of-hospital cardiac arrest in the 1990's:a population-based study in the Maastricht area on incidence,characteristics and survival 19972.胡大一;丁荣晶推动自动体外除颤器应用提高院外心脏骤停患者生存率 20083.王方正;张澍;任自文植入型心律转复除颤器治疗的适应证 20024.Priori SG;Aliot E;Blomstrom-Lundqvist C Task Force on Sudden Cardiac Death of the European Society of Cardiology 20015.Lloyd-Jones D;Adams R J;Brown TM Heart disease and stroke statistics-2010 update:a report from the American Heart Association 20126.Kong MH;Fonarow GC;Peterson ED Systematic review of the incidence of sudden cardiac death in the United States 20117.Dudas K;Lappas G;Stewart S Trends in out-of-hospital deaths due to coronary heart disease in Sweden(1991 to 2006) 20118.Gerber Y;Jacobsen S J;Frye RL Sevular trends in deaths from cardiovascular diseases:a 25-year community study 20069.Tokashiki T;Muratani A;Kimura Y Sudden death in the general population in Okinawa:Incidence and causes of death 199910.Tungsanga K;Sriboonlue P Sudden unexplained death syndrome in Northeast Thailand 199311.Hua W;Zhang LF;Wu YF Incidence of sudden cardiac death in China:analysis of 4 regional populations 200912.Mirowski M;Mower MM;Staewen WS Standby automatic defibrillator:An approach to prevention of sudden coronary death 197013.Mirowski M;Reid PR;Mower MM Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in humanbeings 198014.Moser S;Troup P;Saksena S Nonthoractomy implantable defibrillator system 198815.The AVID investigators A Comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal sustained ventricular arrhythmias 199716.Connolly SJ;Gent M;Roberts RS Canadian Implantable Defibrillator Study(CIDS):A randomized trial of the implantable cardioverter against amiodarone 200017.Kuck KH;Cappato R;Siebels J for the CASH investigators.Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest 200018.Connolly SJ;Hallstrom AP;Cappato R Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials.AVID,CASH and CIDS studies.Antiarrhythmics vs Implantable Defibrillator study.Cardiac Arrest Study Hamburg.Canadian Implantable Defibrillator Study 200019.Moss A J;Hall WJ;Cannom DS Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia.Multicenter Automatic Defibrillator Implantation Trial Investigators 1996 20.Buxton AE;Lee KL;Fisher JD A randomized study of the prevention of sudden death in patients with coronary artery disease.Multicenter Unsustained Tachycardia Trial Investigators 199921.Moss AJ;Zareba W;Hall WJ Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction 200222.Goldenberg I;Gillespie J;Moss A J Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial Ⅱ.Long-term benefit of primary prevention with an implantable cardioverter-defibrillator:an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial Ⅱ 201023.Kadish A;Dyer A;Daubert JP Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy 200424.Bardy GH;Lee KL;Mark DB Amiodarone or an implantable cardioverter defibrillator for congestive heart failure 200525.Gregoratos G;Cheitlin MD;Conill A ACC/AHA guidelines for implantation of cardiac pacemaker and antiarrhayrhmia devices:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation) 199826.Gregoratos G;Abrams J;Epstein AE ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) 200227.Hunt SA;Abraham WT;Chin MH ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult:A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to update the 2001 guidelines for the evaluation and management of heart failure) 200528.Epstein AE;Dimarco JP;Ellenbogen KA ACC/AHA/HRS 2008 Guidelines for Device-Baced Therapy of Cardiac Rhythm Abnormalities:a report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines (writing commit to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices):developed in collaboration with American Association for Thoracic surgery 200829.Zipes DP;Camm AJ;Borggrefe M ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death 200630.Tracy CM;Epstein AE;Darbar D2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.[corrected] 201231.梁义秀;宿燕岗;柏瑾心脏性猝死一级与二级预防植入型心律转变除颤器患者临床特征单中心分析 201232.宿燕岗;吴妍;柏瑾ICD适应证患者及主管医生的问卷调查 201033.程中伟;朱孔博;陈太波植入型心律转复除颤器在一级预防心力衰竭患者中的应用 201134.Softeriades ES;Evans JC;Larson MG Incidence and prognosis of syncope 200235.Olshansky B;Poole JE;Johnson G Syncope Predicts the outcome of cardiomyopathy patients:analysis of the SCD-HeFT study 200836.deSousa MR;Morillo CA;Rabelo FT Non-sustained ventricular tachycardia as a predictor of sudden cardiac deathin patients with left ventricular dysfunction:a meta-analysis 200837.Miwa Y;Yoshino H;Hoshida K Risk stratification for serious arrhythmic events using nonsustained ventricular tachycardia and heart rate turbulence detected by 24-hour holter electrocardiograms in patients with left ventricular dysfunction 201238.Yap YG;Duong T;Bland JM Optimising the dichotomy limit for left ventricular ejection fraction in selectingpatients for defibrillator therapy after myocardial infarction 200739.Buxton AE;Lee KL;Hafley GE Limitations of ejection fraction for predicrion of sudden death risk in patients with coronary artery disease:Lessons from the MUSTT study 200740.Chen J;Johnson G;Hellkamp AS Rapid-rate nonsustained ventricular tachycardia found on implantablecardioverter-defibrillator interrogation:relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) 201341.Kusumoto FM;Calkins H;Boehmer J HRS/ACC/AHA expert consensus statement on the use of implantable cardioverterdefibrillator therapy in patients who are not included or not well represented in clinical trials 201442.Newby LK;Jesse RL;Babb JD ACC 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations:a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents 201243.Hohnloser SH;Kuck KH;Dorian P Prophylactic use of an implantable cardioverter-defibrillator after acutemyocardial infarction 200444.Steinbeck G;Andresen D;Seidl K for the IRIS Investigators.Defbrillator implantation early after myocardial infarction 200945.Volpi A;Cavalli A;Santoro L Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction:results of the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI-2) database 199846.Newby KH;Thompson T;Stebbins A Sustained ventricular arrhythmias in patients receiving thrombolytictherapy:incidence and outcomes.The GUSTO Investigators 199847.Mehta RH;Starr AZ;Lopes RD Incidence of and outcomes associated with ventricular tachycardia or fbrillation in patients undergoing primary percutaneous coronary intervention 200948.The PURSUIT Trial Investigators Inhibition of platelet glycoprotein Ⅱ b/Ⅲa with eptifbatide in patients with acute coronary syndromes 199849.Piccini JP;White JA;Mehta RH Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segmentelevation acute coronary syndromes 201250.Bigger JT Jr Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery.Coronary Artery Bypass Graft (CABG) Patch Trial Investigators 199751.Barsheshet A;Goldenberg I;Moss AJ Effect of elapsed time from coronary revasculariza-tion to implantation of a cardioverter defibrillator on long-term survival in the MADIT-Ⅱ trial 201152.Goldenberg I;Moss A J;McNitt S Time dependence of defbrillator beneft after coro-nary revascularization in the multicenter automatic defibrillator implanta-tion trial(MADIT)-Ⅱ 200653.Nageh MF;Kim JJ;Chung J The role of implantable cardioverter defibrillators in high-risk CABG patients identified early post-cardiac surgery 201154.John JM;Hussein A;Imran N Underutilization of implantable cardioverter defibrillators post coronary artery bypass grafting in patients with systolic dysfunction 201055.Cook JR;Rizo-Patron C;Curtis AB Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus ImplantableDefibrillators(AVID)registry 200256.Kadish A;Schaechter A;Subacius H Levine J.Patients with recently diagnosed nonischemic cardiomyopathy beneftfrom implantable cardioverter-defibrillators 200657.McNamara DM;Starling RC;Cooper LT for the IMAC Investigators.Clinical and demographic predictors of outcomesin recent onset dilated cardiomyopathy:results of the IMAC (Intervention in Myocarditis and Acute Cardiomyopathy)-2 study 201158.Zecchin M;Merlo M;Pivetta A How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?" 201259.Meyer C;Schueller P;Rodenbeck A Primary and secondary prevention of ventricular arrhythmias in dilated cardiomyopathy:nonsustained,sustained,and incessant 200960.Matlock DD;Peterson PN;Wang Y Variation in use of dualchamber implantable cardioverter-defibrillators:results from the national cardiovascular data registry 201261.Gregoratos G;Abrams J;Epstein AE ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) 200262.Friedman PA;Bradley D;Koestler C A prospective randomized trial of single-or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention 2014 63.Wilkoff BL;Cook JR;Epstein AE for the Investigators VV ⅡDT.Dual chamber pacing or ventricular backup pacingin patients with an implantable defbrillator:the Dual-chamber and VVI Implantable Defbrillator (DAVID) trial 2002 64.Peleska B;Blazek Z Effect of serial inductivity in condenser defibrillators on the defibrillation threshold of the heart and proposals for a modification of the earlier prema type defibrillator 196365.Pires L;Johnson KM Intraoperative testing of the implantable cardioverter-defibrillator:how much Is enough 200666.Strickberger SA;Klein GJ Is defi rillation testing required for defibrillator implantation 200467.Brignole M;Occhetta E;Bongiorni MG Clinical evaluation of defibrillation testing in an unselected populationof 2,120 consecutive patients undergoing first implantable cardioverterdefibrillator implant 201268.Birnie D;Tung S;Simpson C Complications associated with defibrillation threshold testing:The Canadian experience 200869.Healey JS;Hohnloser SH;Glikson M The rationale and design of the Shockless IMPLant Evaluation (SIMPLE) trial:a randomized,controlled trial of defibrillation testing at the time of defibrillator implantation 201270.陈泗林;林纯莹;费洪文心脏再同步治疗起搏参数优化对血流动力学的影响及随访 200971.陈柯萍减少植入型心律转复除颤器放电是临床医生必须重视的问题 201272.张澍;陈柯萍;黄德嘉心血管植入型电子器械术后随访的专家共识 201273.华伟;丁立刚;张澍远程家庭监测功能在心脏再同步治疗中的应用 201074.Varma N;Epstein AE;Irimpen A Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up:the Lumos-t Safely Reduces Routine Office Device Follow-up (TRUST) trial 201075.Crossley GH;Boyle A;Vitense H The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial:The value of wireless remote monitoring with automatic clinician alerts 201176.Wathen M;Sweeney MO;De Groot PJ Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease 200177.Wathen MS;De Groot P J;Sweeney MO Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators pacing fast ventricular tachycardia reduces shock therapies(PainFREE Rx Ⅱ)trial results 200478.Gasparini M;Menozzi C;Proctemer A A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention:the RELEVANT[Role of long dEtection window programming in patients with LEft VentriculAr dysfunction,Non-ischemic eTiology in primary preventi 200979.Moss AJ;Schuger C;Beck CA Reduction in inappropriate therapy and mortality through ICD programming 201280.Gasparini M;Proclemer A;Klersy C Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery:the ADVANCE Ⅲ randomized clinical trial 201381.Wilkoff BL;Williamson BD;Stern RS Strategic programming of detection and therapy parameters in implantable cardioverterdefibrillators reduces shocks in primary prevention patients results from the PREPARE(Primary Prevention Parameters Evaluation)study 200882.Wilkoff BW;Ousdigian KT;Sterns LD A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators results from the prospective randomized multicenter EMPIRIC trial 2006引用本文格式：中华医学会心电生理和起搏分会.中华医学会心血管病学分会.中国医师协会心律学专业委员会植入型心律转复除颤器治植入型心律转复除颤器治疗的中国专家共识[期刊论文]-中华心律失常学杂志 2014(4)。
